Endonovo Therapeutics Highlights Feasibility Study Results of Its Electroceutical Therapy in Reducing Proteinuria in Chronic Kidney Disease Patients
01 mai 2018 07h35 HE
|
Endonovo Therapeutics, Inc.
Company to Conduct Larger Clinical Study to Evaluate Its Electroceutical™ Therapy in Chronic Kidney Disease LOS ANGELES, CA, May 01, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics,...
DiaMedica Therapeutics Announces Appointment of Scott Kellen as Chief Financial Officer
05 avr. 2018 07h15 HE
|
DiaMedica Therapeutics Inc.
MINNEAPOLIS, April 05, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “Company”) (TSX-V:DMA) (OTCQB:DMCAF) is pleased to announce the appointment of Mr. Scott Kellen as Chief Financial...
DiaMedica Therapeutics Announces Final Closing of Private Placement
29 mars 2018 18h08 HE
|
DiaMedica Therapeutics Inc.
MINNEAPOLIS, March 29, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “Company” and “DiaMedica”) (TSX-V:DMA) (OTCQB:DMCAF) is pleased to announce the successful completion of the second...
DiaMedica Therapeutics Announces Closing of Private Placement
20 mars 2018 17h40 HE
|
DiaMedica Therapeutics Inc.
MINNEAPOLIS, March 20, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “Company”) (TSX-V:DMA) (OTCQB:DMCAF) is pleased to announce the successful completion of the first closing of a...
DiaMedica Announces First Enrollment in its PHASE 2 “REMEDY” TRIAL for Acute Ischemic Stroke
22 févr. 2018 07h00 HE
|
DiaMedica Therapeutics Inc.
DM199 may offer an effective and safe treatment with a significantly longer treatment window (24 hours) compared to the current standard of careREMEDY trial lead by prominent neurologist Dr. Bruce...
DiaMedica to Present at the 14th Annual Noble Investor Conference
29 janv. 2018 08h45 HE
|
DiaMedica Therapeutics Inc.
MINNEAPOLIS, Jan. 29, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (TSXV:DMA) (OTCQB:DMCAF), today announced that Mr. Rick Pauls, its President and CEO, will present at Noble Capital...
Streetwise Reports Examines Analyst’s View of ‘One of the Most Undervalued Biotech Companies in Canada’
07 déc. 2017 08h45 HE
|
Streetwise Reports Llc
SAN FRANCISCO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- David Kideckel, an analyst with Beacon Securities Ltd., explained the investment thesis for this clinical-stage life sciences firm. Included in this...
Satellite Healthcare to Present at American Society of Nephrology Annual Kidney Week Conference
31 oct. 2017 09h03 HE
|
Satellite Healthcare
SAN JOSE, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading not-for-profit dialysis provider, today announced it will present three posters and host a NephTalk lounge for...
Satellite Healthcare Awards $800,000 in Applied Pragmatic Clinical Research Grants
04 oct. 2017 15h42 HE
|
Satellite Healthcare
SAN JOSE, Calif., Oct. 04, 2017 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading not-for-profit dialysis provider, today awarded $800,000 in Applied Pragmatic Clinical Research Grants to four...
Satellite Healthcare Recognizes National Kidney Month with Educational Presentations at the Annual Dialysis Conference
09 mars 2017 09h00 HE
|
Satellite Healthcare
SAN JOSE, Calif., March 09, 2017 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading national not-for-profit dialysis care provider, today recognizes World Kidney Day and National Kidney Month by...